Verubecestat - Ligand Pharmaceuticals/Merck & Co
Alternative Names: MK-8931; SCH-900931Latest Information Update: 05 Nov 2023
At a glance
- Originator Merck & Co
- Class Amides; Amines; Antidementias; Fluorobenzenes; Pyridines; Small molecules; Thiadiazines
- Mechanism of Action BACE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alzheimer's disease